This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Abcam | Numis downgrades to Hold from add; TP to 510p from 560p |
| Al Noor Hospitals Group | HSBC ups to overweight from neutral; TP to 1,065p from 785p |
| Ashtead Group | Jefferies ups TP to 1050p from 1000p, Buy |
| Berendsen | RBC downgrades to sector perform from outperform; ups TP to 1030p from 1000p |
| Hellermanntyton Group | JP Morgan ups TP to 370p from 360p, overweight |
| Intertek Group | Barclays cuts TP to 3370p from 3455p, overweight |
| Intertek Group | JP Morgan cuts TP to 3,165p from 3,240p, neutral |
| ISG | Numis ups TP to 345p, add |
| Pace | Jefferies ups TP to 467p from 338p, Buy |
| Pearson | UBS cuts TP to 1200p from 1400p, Buy |
| Pearson | SocGen cuts TP to 1030p from 1200p, Hold |
| Prudential | JP Morgan ups TP to 1028p from 920p, underweight |
| Quintain Estates and Development | JP Morgan ups TP to 130p from 110p, overweight |
| Rentokil Initial | Barclays ups TP to 143p from 117p, overweight |
| Rightmove | Nomura ups TP to 3000p from 2900p, Buy |
| Smiths News | JP Morgan cuts TP to 221p from 236p, overweight |
| Ultra Electronics | Deutsche Bank ups TP to 1765p from 1750p |
| William Hill | Barclays ups TP to 393p from 375p, Equalweight |
| WPP | JP Morgan cuts TP to 1,552p from 1,583p, overweight |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research